Covered recipient · General Payments record
NINA V NATION
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,453.42
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $595.78 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $137.44 | 7 |
| Amgen Inc. | $114.60 | 5 |
| ABBVIE INC. | $82.00 | 4 |
| Novo Nordisk AS | $76.97 | 4 |
| Astellas Pharma US Inc | $57.79 | 2 |
| Lilly USA, LLC | $38.80 | 2 |
| Abbott Laboratories | $24.61 | 1 |
| GlaxoSmithKline, LLC. | $16.95 | 1 |
| Antares Pharma, Inc. | $16.13 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.84 | 1 |
| Acerta Pharma LLC | $14.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.61 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124923249 | CMS |
| ABBVIE INC. | $24.80 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107721318 | CMS |
| ABBVIE INC. | $16.89 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107721320 | CMS |
| ABBVIE INC. | $23.85 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107721322 | CMS |
| ABBVIE INC. | $16.46 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107721324 | CMS |
| Amgen Inc. | $24.06 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117638813 | CMS |
| Amgen Inc. | $20.75 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117638815 | CMS |
| Amgen Inc. | $24.51 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117638817 | CMS |
| Amgen Inc. | $16.14 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117638819 | CMS |
| Amgen Inc. | $29.14 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117337053 | CMS |
| Antares Pharma, Inc. | $16.13 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146516872 | CMS |
| Astellas Pharma US Inc | $28.00 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139477504 | CMS |
| Astellas Pharma US Inc | $29.79 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139500364 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.65 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105669163 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.84 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086311755 | CMS |
| GlaxoSmithKline, LLC. | $16.95 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116578522 | CMS |
| Lilly USA, LLC | $17.00 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920920 | CMS |
| Lilly USA, LLC | $21.80 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135907858 | CMS |
| Novo Nordisk Inc | $15.70 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100654253 | CMS |
| Novo Nordisk Inc | $17.62 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100519123 | CMS |
| Novo Nordisk Inc | $21.97 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100468774 | CMS |
| Novo Nordisk Inc | $21.68 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100485625 | CMS |
| PFIZER INC. | $18.51 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131544917 | CMS |
| PFIZER INC. | $12.55 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130916546 | CMS |
| PFIZER INC. | $27.38 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131592894 | CMS |
| PFIZER INC. | $23.10 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131661600 | CMS |
| PFIZER INC. | $23.41 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131889467 | CMS |
| PFIZER INC. | $23.25 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130877474 | CMS |
| PFIZER INC. | $9.24 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131164304 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.